| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |